IRF7 and central nervous system cancer: Moreover, the prognostic analysis revealed that patients in the IRF7 high‐expression group had a worse prognosis in The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) cohorts (p < 0.05) (Figure S2G,H).